Feasibility and perioperative outcomes of robotic-assisted surgery in the management of recurrent ovarian cancer: A multi-institutional study

Pedro F. Escobar, Kimberly L. Levinson, Javier Magrina, Martin A. Martino, Richard R. Barakat, Amanda N. Fader, Mario M. Leitao

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Objectives Minimally invasive surgery for recurrent ovarian cancer is generally not performed. The aim of this study was to assess the feasibility and surgical outcomes of robotic-assisted surgery in the management of recurrent ovarian cancer. Methods Eligible patients included those with confirmed recurrent ovarian cancer amenable to surgical resection and in which a complete resection was thought to be feasible with the use of the robotic platform. Patients with evidence of carcinomatosis were not considered for a robotic approach. Clinical and pathologic data were abstracted from the medical records. Appropriate statistical tests were performed using SPSS statistical software program (SPSS 20.0 Inc., Chicago, IL). Results A total of 48 patients were identified. Thirty-six (75%) patients had a recurrent mass or masses isolated to one anatomic region (pelvis or abdomen). Conversion to laparotomy was necessary in 4 (8.3%) cases. In cases not requiring conversion to laparotomy, the median operative time, EBL, and length of stay were 179.5 min, 50 cc, and 1 day, respectively. An optimal debulking was achieved in 36 (82%) cases. Complications occurred in 6 (13.6%) cases. The median operative time, EBL, length of stay, and complications were all statistically significantly lower in the cases not converted to laparotomy compared to those that were (p < 0.001). Conclusions This study suggests that select patients with recurrent ovarian cancer in the absence of carcinomatosis may be candidates for secondary surgical cytoreduction via a robotic approach. Surgical and postoperative outcomes appear to be favorable compared to reports of laparotomy in recurrent ovarian cancer.

Original languageEnglish (US)
Pages (from-to)253-256
Number of pages4
JournalGynecologic Oncology
Volume134
Issue number2
DOIs
StatePublished - 2014

Fingerprint

Robotics
Ovarian Neoplasms
Laparotomy
Operative Time
Length of Stay
Carcinoma
Minimally Invasive Surgical Procedures
Pelvis
Abdomen
Medical Records
Software

Keywords

  • Minimally invasive surgery
  • Robotic surgery
  • Surgical technique

ASJC Scopus subject areas

  • Obstetrics and Gynecology
  • Oncology

Cite this

Escobar, P. F., Levinson, K. L., Magrina, J., Martino, M. A., Barakat, R. R., Fader, A. N., & Leitao, M. M. (2014). Feasibility and perioperative outcomes of robotic-assisted surgery in the management of recurrent ovarian cancer: A multi-institutional study. Gynecologic Oncology, 134(2), 253-256. https://doi.org/10.1016/j.ygyno.2014.05.007

Feasibility and perioperative outcomes of robotic-assisted surgery in the management of recurrent ovarian cancer : A multi-institutional study. / Escobar, Pedro F.; Levinson, Kimberly L.; Magrina, Javier; Martino, Martin A.; Barakat, Richard R.; Fader, Amanda N.; Leitao, Mario M.

In: Gynecologic Oncology, Vol. 134, No. 2, 2014, p. 253-256.

Research output: Contribution to journalArticle

Escobar, Pedro F. ; Levinson, Kimberly L. ; Magrina, Javier ; Martino, Martin A. ; Barakat, Richard R. ; Fader, Amanda N. ; Leitao, Mario M. / Feasibility and perioperative outcomes of robotic-assisted surgery in the management of recurrent ovarian cancer : A multi-institutional study. In: Gynecologic Oncology. 2014 ; Vol. 134, No. 2. pp. 253-256.
@article{468fdba3460e4e988e6b1ba4ccaa062e,
title = "Feasibility and perioperative outcomes of robotic-assisted surgery in the management of recurrent ovarian cancer: A multi-institutional study",
abstract = "Objectives Minimally invasive surgery for recurrent ovarian cancer is generally not performed. The aim of this study was to assess the feasibility and surgical outcomes of robotic-assisted surgery in the management of recurrent ovarian cancer. Methods Eligible patients included those with confirmed recurrent ovarian cancer amenable to surgical resection and in which a complete resection was thought to be feasible with the use of the robotic platform. Patients with evidence of carcinomatosis were not considered for a robotic approach. Clinical and pathologic data were abstracted from the medical records. Appropriate statistical tests were performed using SPSS statistical software program (SPSS 20.0 Inc., Chicago, IL). Results A total of 48 patients were identified. Thirty-six (75{\%}) patients had a recurrent mass or masses isolated to one anatomic region (pelvis or abdomen). Conversion to laparotomy was necessary in 4 (8.3{\%}) cases. In cases not requiring conversion to laparotomy, the median operative time, EBL, and length of stay were 179.5 min, 50 cc, and 1 day, respectively. An optimal debulking was achieved in 36 (82{\%}) cases. Complications occurred in 6 (13.6{\%}) cases. The median operative time, EBL, length of stay, and complications were all statistically significantly lower in the cases not converted to laparotomy compared to those that were (p < 0.001). Conclusions This study suggests that select patients with recurrent ovarian cancer in the absence of carcinomatosis may be candidates for secondary surgical cytoreduction via a robotic approach. Surgical and postoperative outcomes appear to be favorable compared to reports of laparotomy in recurrent ovarian cancer.",
keywords = "Minimally invasive surgery, Robotic surgery, Surgical technique",
author = "Escobar, {Pedro F.} and Levinson, {Kimberly L.} and Javier Magrina and Martino, {Martin A.} and Barakat, {Richard R.} and Fader, {Amanda N.} and Leitao, {Mario M.}",
year = "2014",
doi = "10.1016/j.ygyno.2014.05.007",
language = "English (US)",
volume = "134",
pages = "253--256",
journal = "Gynecologic Oncology",
issn = "0090-8258",
publisher = "Academic Press Inc.",
number = "2",

}

TY - JOUR

T1 - Feasibility and perioperative outcomes of robotic-assisted surgery in the management of recurrent ovarian cancer

T2 - A multi-institutional study

AU - Escobar, Pedro F.

AU - Levinson, Kimberly L.

AU - Magrina, Javier

AU - Martino, Martin A.

AU - Barakat, Richard R.

AU - Fader, Amanda N.

AU - Leitao, Mario M.

PY - 2014

Y1 - 2014

N2 - Objectives Minimally invasive surgery for recurrent ovarian cancer is generally not performed. The aim of this study was to assess the feasibility and surgical outcomes of robotic-assisted surgery in the management of recurrent ovarian cancer. Methods Eligible patients included those with confirmed recurrent ovarian cancer amenable to surgical resection and in which a complete resection was thought to be feasible with the use of the robotic platform. Patients with evidence of carcinomatosis were not considered for a robotic approach. Clinical and pathologic data were abstracted from the medical records. Appropriate statistical tests were performed using SPSS statistical software program (SPSS 20.0 Inc., Chicago, IL). Results A total of 48 patients were identified. Thirty-six (75%) patients had a recurrent mass or masses isolated to one anatomic region (pelvis or abdomen). Conversion to laparotomy was necessary in 4 (8.3%) cases. In cases not requiring conversion to laparotomy, the median operative time, EBL, and length of stay were 179.5 min, 50 cc, and 1 day, respectively. An optimal debulking was achieved in 36 (82%) cases. Complications occurred in 6 (13.6%) cases. The median operative time, EBL, length of stay, and complications were all statistically significantly lower in the cases not converted to laparotomy compared to those that were (p < 0.001). Conclusions This study suggests that select patients with recurrent ovarian cancer in the absence of carcinomatosis may be candidates for secondary surgical cytoreduction via a robotic approach. Surgical and postoperative outcomes appear to be favorable compared to reports of laparotomy in recurrent ovarian cancer.

AB - Objectives Minimally invasive surgery for recurrent ovarian cancer is generally not performed. The aim of this study was to assess the feasibility and surgical outcomes of robotic-assisted surgery in the management of recurrent ovarian cancer. Methods Eligible patients included those with confirmed recurrent ovarian cancer amenable to surgical resection and in which a complete resection was thought to be feasible with the use of the robotic platform. Patients with evidence of carcinomatosis were not considered for a robotic approach. Clinical and pathologic data were abstracted from the medical records. Appropriate statistical tests were performed using SPSS statistical software program (SPSS 20.0 Inc., Chicago, IL). Results A total of 48 patients were identified. Thirty-six (75%) patients had a recurrent mass or masses isolated to one anatomic region (pelvis or abdomen). Conversion to laparotomy was necessary in 4 (8.3%) cases. In cases not requiring conversion to laparotomy, the median operative time, EBL, and length of stay were 179.5 min, 50 cc, and 1 day, respectively. An optimal debulking was achieved in 36 (82%) cases. Complications occurred in 6 (13.6%) cases. The median operative time, EBL, length of stay, and complications were all statistically significantly lower in the cases not converted to laparotomy compared to those that were (p < 0.001). Conclusions This study suggests that select patients with recurrent ovarian cancer in the absence of carcinomatosis may be candidates for secondary surgical cytoreduction via a robotic approach. Surgical and postoperative outcomes appear to be favorable compared to reports of laparotomy in recurrent ovarian cancer.

KW - Minimally invasive surgery

KW - Robotic surgery

KW - Surgical technique

UR - http://www.scopus.com/inward/record.url?scp=84905565122&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84905565122&partnerID=8YFLogxK

U2 - 10.1016/j.ygyno.2014.05.007

DO - 10.1016/j.ygyno.2014.05.007

M3 - Article

C2 - 24844594

AN - SCOPUS:84905565122

VL - 134

SP - 253

EP - 256

JO - Gynecologic Oncology

JF - Gynecologic Oncology

SN - 0090-8258

IS - 2

ER -